Lumbar extradural hemangiomas: report of three cases.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 9974054)

Published in AJNR Am J Neuroradiol on January 01, 1999

Authors

A Rovira1, A Rovira, J Capellades, M Zauner, R Bella, M Rovira

Author Affiliations

1: Servei de Diagnòstic per Imatge, Consorci Hospitalari del Parc Taulí, Sabadell, Spain.

Articles citing this

Pure epidural cavernous hemangioma of the cervical spine that presented with an acute sensory deficit caused by hemorrhage. Yonsei Med J (2006) 1.15

Dorsal spinal epidural cavernous hemangioma. J Craniovertebr Junction Spine (2010) 1.08

Extradural spinal cavernous angiomas: report of seven cases. Neurosurg Rev (2005) 0.99

Extradural lumbosacral cavernous hemangioma. Eur Spine J (2003) 0.99

MRI diagnosis and preoperative evaluation for pure epidural cavernous hemangiomas. Neuroradiology (2009) 0.97

Epidural cavernous hemangioma of the spine: magnetic resonance imaging findings. Radiol Bras (2015) 0.90

A rare case of extradural lumbar nerve root cavernoma. Eur Spine J (2011) 0.84

Spinal extradural cavernous haemangioma in an elderly man. BMJ Case Rep (2012) 0.77

Spinal epidural haemangioma associated with extensive gastrointestinal haemangiomas. A case report. Interv Neuroradiol (2005) 0.76

A case of dumbbell-shaped epidural cavernous angioma in the lumbar spine. Surg Neurol Int (2015) 0.75

Osteolytic mass bridging two cervical vertebrae: Unusual presentation of a vertebral body hemangioma. Radiol Case Rep (2015) 0.75

Haemangioma, an uncommon cause of an extradural or intradural extramedullary mass: case series with radiological pathological correlation. Insights Imaging (2015) 0.75

Lumbar extradural dumbbell cavernous hemangioma: A rare lesion. J Neurosci Rural Pract (2013) 0.75

Solitary spinal epidural cavernous haemangiomas as a rare cause of myelopathy. BMJ Case Rep (2015) 0.75

Articles by these authors

MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology (2007) 2.47

Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology (2008) 2.45

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42

A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol (2007) 2.34

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol (2000) 2.10

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology (2003) 2.04

[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93

MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology (2004) 1.77

Absence of response to early transcranial magnetic stimulation in ischemic stroke patients: prognostic value for hand motor recovery. Stroke (1999) 1.73

Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol (2007) 1.72

Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology (2000) 1.71

Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax (2001) 1.66

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63

Global and regional gray matter reductions in ADHD: a voxel-based morphometric study. Neurosci Lett (2005) 1.60

Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant (2010) 1.52

Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler (2009) 1.49

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46

Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42

[Body mass index influence in the insulin action mechanisms]. An Med Interna (1998) 1.38

[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study]. Med Clin (Barc) (1997) 1.37

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37

Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis (2000) 1.34

Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27

Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26

Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol (1991) 1.25

Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Mult Scler (2008) 1.21

A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect (2012) 1.17

Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J (1998) 1.14

High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13

MRI findings in Möbius syndrome: correlation with clinical features. Neurology (2000) 1.13

Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol (2005) 1.12

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob Agents Chemother (2000) 1.11

Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis (2004) 1.10

mTOR signalling in human cancer. Clin Transl Oncol (2007) 1.09

Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology (2006) 1.09

Brainstem lesions in clinically isolated syndromes. Neurology (2010) 1.09

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. Br J Cancer (2011) 1.06

Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant (2000) 1.06

Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant (1996) 1.05

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler (2009) 1.04

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology (2007) 1.04

Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia (1995) 1.04

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04

Transcranial magnetic stimulation after pure motor stroke. Clin Neurophysiol (2002) 1.04

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04

Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler (2008) 1.03

Patulin accumulation in apples by Penicillium expansum during postharvest stages. Lett Appl Microbiol (2007) 1.02

Automatic detection of patients with nosocomial infection by a computer-based surveillance system: a validation study in a general hospital. Infect Control Hosp Epidemiol (2006) 1.00

Clinical impact of early brain atrophy in clinically isolated syndromes. Mult Scler (2013) 1.00

Vertebral artery occlusion after acute cervical spine trauma. Spine (Phila Pa 1976) (2000) 0.99

Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology (1999) 0.99

L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int J Clin Pharmacol Res (1995) 0.99

The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplant (2004) 0.99

One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.99

A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology (2010) 0.98

Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplant (2005) 0.98

Asterixis associated with anatomic cerebral lesions: a study of 45 cases. Acta Neurol Scand (1995) 0.98

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant (2004) 0.98

Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98

C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol (2010) 0.98

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2000) 0.98

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol (2001) 0.97

Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol (1991) 0.97

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler (2013) 0.97

Cerebral microembolism in acute spontaneous internal carotid artery dissection. Neurology (2000) 0.96

The proteasome: a novel target for anticancer therapy. Clin Transl Oncol (2006) 0.95

Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr Scand (2010) 0.95

DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer. Oncogene (2010) 0.94

Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study. Stroke (1999) 0.94

MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique? Neurology (2011) 0.94

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.94

Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes: increased abundance of GLUT1 and GLUT4 glucose transporter proteins. J Endocrinol (2000) 0.94

Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc (2005) 0.93

Increased glucose transporter (GLUT4) protein expression in hyperthyroidism. Biochem Biophys Res Commun (1990) 0.93

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol (1999) 0.93

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings. Bone Marrow Transplant (2010) 0.93

A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses (1996) 0.92

Cardiotoxicity of tyrosine-kinase-targeting drugs. Cardiovasc Hematol Agents Med Chem (2010) 0.92

[Vertebrobasilar abnormalities in patients with hemifacial spasm: MR-angiography findings]. Rev Neurol (1999) 0.92

Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol (2003) 0.92

Blood lymphocytes are sensitized to branchial plexus nerves in patients with neuralgic amyotrophy. Acta Neurol Scand (1991) 0.92

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis. Mult Scler (2010) 0.91

Study of tuberculous meningitis by CT. Neuroradiology (1980) 0.91

Radiologic findings in two cases of acute Schmörl's nodes. AJNR Am J Neuroradiol (1999) 0.91

Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism. Diabetologia (1996) 0.91

Some aspects of the spinal cord circulation in cervical myelopathy. Neuroradiology (1975) 0.90

Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett (2001) 0.90

Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. J Neurol Sci (1990) 0.90

Caspase-3 is related to infarct growth after human ischemic stroke. Neurosci Lett (2007) 0.90

Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology (1996) 0.90

Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol (2008) 0.90

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant (2001) 0.89